EU-funded scientists have discovered that stem cells from one of the immune system's main organs can be reprogrammed to form hair follicle stem cells. The key lies in altering the environment in which the cells are grown. These results demonstrate that it is possible to alter stem cells without genetic manipulation. Details of the study are published in Nature.
Read more ...
EMIS Acquires Majority Stake in Pharmacy Software Company Rx Systems Limited
EMIS Group plc (AIM: EMIS), the UK's leading supplier of healthcare software to GPs, today announces that it has acquired 78.9% of the issued share capital of Rx Systems Limited ("RX"), a pharmacy software and services company, for a total consideration of up to £9.95 million.
Read more ...
Pharmacy's online service helps care homes improve their support for residents
Pharmacy Plus launched its new Online Service, the service which is freely available to all its customers offers a unique online tool that provides care homes with data and analysis relating to individual patients medication history and drug usage, to enable them to offer improved and personalised care to all their residents.
Read more ...
Data on Electronic Sampling, Online Promotion, Tech-Enabled Reps, Customer Service, and iPads
Pharmaceutical and healthcare market research company Manhattan Research releases the tenth version of ePharma Physician®, its study focused on physicians connecting with pharmaceutical and biotech companies through the Internet, tech-enabled reps, and online promotion. ePharma Physicians comprise 88% of the U.S. physician population in 2010, up from 64% in 2006.
Read more ...
New tools needed to relieve malaria burden in Africa
Researchers in the UK have demonstrated that the tools currently available for combating malaria could dramatically reduce the burden of malignant malaria on parts of Africa if a comprehensive, sustained intervention programme were in place. The findings, published in the Public Library of Science (PLoS) Medicine journal, are an outcome of the TRANSMALARIABLOC (Blocking malaria transmission by vaccines, drugs and immune mosquitoes: efficacy assessment and targets) project, financed with EUR 3 million under the Health Theme of the Seventh Framework Programme (FP7).
Read more ...
An international team of scientists has identified 95 genetic variants associated with high blood cholesterol and triglyceride levels which are major risk factors for coronary heart disease. The study, published in the journal Nature and funded in part by the EU, could lead to novel ways of preventing and treating heart disease.
Read more ...
Scientists launch new attack against AIDS
EU-funded researchers have developed a new defence against infection from the AIDS (acquired immune deficiency syndrome) virus. The pioneering method involves creating a protective shield that restricts the virus from making contact with a susceptible host cell and penetrating the immune system. Published in the journal Chemistry & Biology, the results pave the way for future pharmaceutical drugs that could combat the disease in its early stages.
Read more ...